Completing data — refresh the page later to see the latest
24136-23-0CC(=O)NCCOC(=O)[C@H](Oc1cccc(C(F)(F)F)c1)c1ccc(Cl)cc1BJBCSGQLZQGGIQ-QGZVFWFLSA-NArhalofenate has been investigated for the treatment of Gout and Hyperuricemia.
Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
Danger
H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]
P264, P264+P265, P270, P273, P280, P301+P316, P305+P351+P338, P321, P330, P337+P317, P391, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 39 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
UsesMBX 102 is used as a new medication to treat and prevent acute gouty flares, also used as URAT 1 inhibitor.
24136-23-0DTXSID301347353CHEMBL2103824